PlainRecalls
FDA Drug Low Class III Terminated

BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880

Reported: February 5, 2014 Initiated: November 15, 2013 #D-1043-2014

Product Description

BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880

Reason for Recall

Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.

Details

Recalling Firm
Actavis Inc
Units Affected
139,944 bottles
Distribution
Nationwide and Puerto Rico
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880. Recalled by Actavis Inc. Units affected: 139,944 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 5, 2014. Severity: Low. Recall number: D-1043-2014.